Passage Bio, Inc. (PASG)
Nasdaq: PASG · Biological Products, (No Diagnostic Substances) · Philadelphia, PA · filing with the SEC since 2019
Who owns Passage Bio, Inc.
As filed with the SECHolders of 5% or more
2
Lynx1 Capital Management LP holds 21% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13D filed Jul 2, 2026 says.
Directors and officers
8
report now, of 26 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Lynx1 Capital Management LP
SCHEDULE 13D · filed Jul 2, 2026 · Common Stock, par value $0.0001 per share · 19.6% in Nov 14, 2025
Baselake Partners, LP
SCHEDULE 13G · filed Jun 25, 2026 · Common Stock, $0.0001 Par Value Per Share
Erste Asset Management GmbH
SCHEDULE 13G/A · filed Nov 14, 2024 · Common Stock · reported falling below 5%, from 5.4% in Nov 14, 2024
Orbimed Advisors LLC
SCHEDULE 13D/A · filed Jul 24, 2025 · COMMON STOCK · reported falling below 5%, from 7.82% in Jul 21, 2025
Vestal Point Capital, LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%
What PASG reports owning in othersstakes of 5% or more, and other ties
Passage Bio, Inc. reports no stake in another company in the record.
Insider tradesForm 4
2sales
0purchases
0sales on a scheduled plan
2people selling
$100,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 40 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Chou William | PRESIDENT AND CEO | 1 | $100,000 | 0 | 0 | $0 |
| Nichols Weston | 10% owner | 0 | $0 | 0 | 1 | $200,000 |
| Borthwick Kathleen | CFO | 1 | $0 | 0 | 0 | $0 |